Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

Biomarkers

Volumn 17, Issue 1, 2012, Pages 48-55

  Zhao, Ying Yong ^a   Cheng, Xian Long ^b   Wei, Feng ^b   Xiao, Xin Yue ^b   Sun, Wen Ji ^a   Zhang, Yongmin ^c   Lin, Rui Chao ^b  

^a NORTHWEST UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Chronic renal failure; Metabonomics; Rats; Serum; UPLC Q TOF MS

Indexed keywords

ADENINE; CERAMIDE; CREATININE; LEVACECARNINE; PHYTOSPHINGOSINE; SPHINGANINE; TRYPTOPHAN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; MALE; METABOLIC CAPACITY; METABOLOMICS; NONHUMAN; PHOSPHOLIPID METABOLISM; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; RAT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADENINE; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; CREATININE; KIDNEY FAILURE, CHRONIC; LYSOPHOSPHOLIPIDS; MALE; METABOLOME; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPTOPHAN;

RATTUS;

EID: 84863012683     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.637180     Document Type: Article

References (36)

1. Cantley LC. (2002). Te phosphoinositide 3-kinase pathway. Science 296:1655-1657.
2. Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W. (2006). Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5:995-1002.
3. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L; United States Renal Data System. (2005). Excerpts from the United States Renal Data System 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 45:A5-7, S1.
4. 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Anal Chim Acta 511:303-312.
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Tird National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12. (Pubitemid 36043346)
6. Desmond O, and Russell M-S. (2006). High-throughput bioanalysis with simultaneous acquisition of metabolic route data using ultra performance liquid chromatography coupled with time-of-fight mass spectrometry. Anal Bioanal Chem 385:114-121.
7. Downes CP, Gray A, Lucocq JM. (2005). Probing phosphoinositide functions in signaling and membrane trafcking. Trends Cell Biol 15:259-268. (Pubitemid 40603895)
8. Dunn WB, Broadhurst DI, Deepak SM, Buch MH, McDowell G, Spasic I, Ellis DI, Brooks N, Kell DB and Neyses L. (2007). Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3:413-426. (Pubitemid 350107675)
9. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. (1992). ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527.
10. Grifn JL, Bollard ME. (2004). Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 5:389-398. (Pubitemid 39276603)
11. Jackson SN, Wang HY, Woods AS, Ugarov M, Egan T, Schultz JA. (2005). Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS. J Am Soc Mass Spectrom 16:133-138. (Pubitemid 40203136)
12. Jia LW, Chen J, Yin PY, Lu X and Xu GW. (2008). Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4:183-189.
13. Johnson KA, Plumb R. (2005). Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. J Pharm Biomed Anal 39:805-810. (Pubitemid 41196103)
14. Kellert M, Wagner S, Lutz U, Lutz WK. (2008). Biomarkers of furan exposure by metabolic profling of rat urine with liquid chromatography-tandem mass spectrometry and principal component analysis. Chem Res Toxicol 21:761-768. (Pubitemid 351498054)
15. Keun HC, Beckonert O, Grifn JL, Richter C, Moskau D, Lindon JC, Nicholson JK. (2002). Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem 74:4588-4593. (Pubitemid 35006452)
16. Khandelwal P, Beyer CE, Lin Q, McGonigle P, Schechter LE, Bach AC 2nd. (2004). Nanoprobe NMR spectroscopy and in vivo microdialysis: New analytical methods to study brain neurochemistry. J Neurosci Methods 133:181-189. (Pubitemid 38147770)
17. Kuhara T. (2005). Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev 24:814-827. (Pubitemid 41641699)
18. Lemmon MA. (2003). Phosphoinositide recognition domains. Trafc 4:201-213. (Pubitemid 36665381)
19. Li F, Lu X, Liu H, Liu M, Xiong Z. (2007). A pharmaco-metabonomic study on the therapeutic basis and metabolic efects of Epimedium brevicornum Maxim. on hydrocortisone-induced rat using UPLC-MS. Biomed Chromatogr 21:397-405. (Pubitemid 46567199)
20. Lindon JC, Holmes E, Nicholson JK. (2006). Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res 23:1075-1088. (Pubitemid 43946133)
21. Lindon JC, Holmes E, Nicholson JK. (2007). Metabonomics in pharmaceutical R&D. FEBS J 274:1140-1151.
22. Locatelli F, Del Vecchio L, Pozzoni P, Manzoni C. (2006). Nephrology: Main advances in the last 40 years. J Nephrol 19:6-11.
23. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. (1990). Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991-1998. (Pubitemid 20192977)
24. Nangaku M. (2004). Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 43:9-17. (Pubitemid 38208370)
25. Nicholson JK, Lindon JC, Holmes E. (1999). 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181-1189.
26. Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J. (2005). A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130:844-849. (Pubitemid 40880105)
27. Rhee SG. (2001). Regulation of phosphoinositide-specifc phospholipase C Annu Rev Biochem 70:281-312.
28. Robertson DG, Reily MD, Baker JD. (2007). Metabonomics in pharmaceutical discovery and development. J Proteome Res 6:526-539. (Pubitemid 46340156)
29. Wenk MR. (2005). Te emerging feld of lipidomics. Nat Rev Drug Discov 4:594-610.
30. Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS. (2005). High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for diferential metabolic pathway profling in functional genomic studies. J Proteome Res 4:591-598. (Pubitemid 40548168)
31. Wolf G. (2006). Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70:1914-1919. (Pubitemid 44863378)
32. Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res 5:554-561. (Pubitemid 43364095)
33. Yin P, Zhao X, Li Q, Wang J, Li J, Xu G. (2006). Metabonomics study of intestinal fstulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/ Q-TOF MS). J Proteome Res 5:2135-2143. (Pubitemid 44330805)
34. Yokozawa T, Zheng PD, Oura H, Koizumi F. (1986). Animal model of adenine-induced chronic renal failure in rats. Nephron 44:230-234. (Pubitemid 16002549)
35. Yu HT. (2003). Progression of chronic renal failure. Arch Intern Med 163:1417-1429. (Pubitemid 36758914)
36. Zoccali C. (2006). Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int 70:26-33. (Pubitemid 44000117)